Bio-Rad Laboratories Inc (BIO)
289.26
+9.13
(+3.26%)
USD |
NYSE |
Apr 23, 09:39
Bio-Rad Laboratories Market Cap: 8.249B for April 23, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 22, 2024 | 7.989B |
| April 19, 2024 | 7.977B |
| April 18, 2024 | 8.014B |
| April 17, 2024 | 8.295B |
| April 16, 2024 | 8.349B |
| April 15, 2024 | 8.567B |
| April 12, 2024 | 8.568B |
| April 11, 2024 | 8.894B |
| April 10, 2024 | 9.442B |
| April 09, 2024 | 9.681B |
| April 08, 2024 | 9.306B |
| April 05, 2024 | 9.257B |
| April 04, 2024 | 9.207B |
| April 03, 2024 | 9.359B |
| April 02, 2024 | 9.375B |
| April 01, 2024 | 9.667B |
| March 28, 2024 | 9.864B |
| March 27, 2024 | 9.969B |
| March 26, 2024 | 9.711B |
| March 25, 2024 | 9.728B |
| March 22, 2024 | 9.995B |
| March 21, 2024 | 10.04B |
| March 20, 2024 | 9.590B |
| March 19, 2024 | 9.596B |
| March 18, 2024 | 9.509B |
| Date | Value |
|---|---|
| March 15, 2024 | 9.511B |
| March 14, 2024 | 9.480B |
| March 13, 2024 | 9.594B |
| March 12, 2024 | 9.617B |
| March 11, 2024 | 9.817B |
| March 08, 2024 | 9.803B |
| March 07, 2024 | 9.679B |
| March 06, 2024 | 9.504B |
| March 05, 2024 | 9.438B |
| March 04, 2024 | 9.544B |
| March 01, 2024 | 9.477B |
| February 29, 2024 | 9.294B |
| February 28, 2024 | 9.421B |
| February 27, 2024 | 9.404B |
| February 26, 2024 | 9.644B |
| February 23, 2024 | 9.639B |
| February 22, 2024 | 9.653B |
| February 21, 2024 | 9.657B |
| February 20, 2024 | 9.803B |
| February 16, 2024 | 9.711B |
| February 15, 2024 | 9.375B |
| February 14, 2024 | 9.351B |
| February 13, 2024 | 9.015B |
| February 12, 2024 | 9.306B |
| February 09, 2024 | 9.275B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
7.851B
Minimum
Oct 30 2023
24.59B
Maximum
Sep 02 2021
14.09B
Average
13.68B
Median
Market Cap Benchmarks
| Agilent Technologies Inc | 39.83B |
| Bruker Corp | 10.99B |
| Azenta Inc | 2.882B |
| Harvard Bioscience Inc | 160.58M |
| Bionano Genomics Inc | 48.24M |
Market Cap Related Metrics
| PS Ratio | 3.170 |
| Price to Book Value | 0.9437 |
| Price to Free Cash Flow | 38.80 |
| Price | 289.26 |
| Earnings Yield | -7.43% |
| Operating PE Ratio | 25.07 |
| Normalized PE Ratio | 27.18 |